Dimmeler, Stefanie,Bonauer, Angelika,Zeiher, Andreas,Urbich, Carmen
申请号：
EP13179146.9
公开号：
EP2684956B1
申请日:
2008.10.30
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
Modulating the function, growth or differentiation of a cell comprises increasing or reducing expression of micro RNA molecule miR-92 in the cell. Independent claims are also included for: (1) a pharmaceutical composition comprising an agent for increasing or reducing miR-92 expression or activity (2) a molecule comprising 15-22 bases that hybridizes with one of SEQ ID NO:1 to SEQ ID NO:5 (not given in the specification). ACTIVITY : Vasotropic Antiarteriosclerotic Cytostatic Antiinflammatory. MECHANISM OF ACTION : miR-92 enhancer miR-92 inhibitor.
